Related Experiment Video
Updated: Sep 21, 2025

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance
Published on: February 17, 2023
Hypertension in Patients with Insulin Resistance: Etiopathogenesis and Management in Children
Veronica Maria Tagi1, Francesca Mainieri1, Francesco Chiarelli1
1Department of Pediatrics, University of Chieti, Via dei Vestini 5, 66100 Chieti, Italy.
Insights
Insulin resistance (IR) contributes to hypertension (HS) in diabetes mellitus (DM) patients. This review highlights IR
Area of Science:
- Endocrinology
- Cardiology
- Pediatrics
Background:
- Insulin resistance (IR) is a significant factor in the development of hypertension (HS) among individuals with diabetes mellitus (DM).
- Recent literature indicates multiple complex pathways linking IR to HS.
- Specific management of HS is crucial for pediatric patients with DM.
Purpose of the Study:
- To elucidate the pathophysiological mechanisms by which IR contributes to HS.
- To outline the specialized treatment principles for HS in children with DM.
Main Methods:
- Literature review of recent studies on IR, HS, and DM.
- Analysis of current European Society of HS and American Academy of Pediatrics guidelines.
Main Results:
- IR influences HS through various interconnected biological pathways.
- Current guidelines emphasize tailored HS treatment strategies for diabetic children.
Conclusions:
- Understanding the IR-HS link is vital for managing hypertension in diabetic children.
- Adherence to updated guidelines ensures optimal HS treatment for this vulnerable population.
Abstract:
Insulin resistance (IR) is a key component in the etiopathogenesis of hypertension (HS) in patients with diabetes mellitus (DM). Several pathways have been found to be involved in this mechanism in recent literature. For the above-mentioned reasons, treatment of HS should be specifically addressed in patients affected by DM. Two relevant recently published guidelines have stressed this concept, giving specific advice in the treatment of HS in children belonging to this group: the European Society of HS guidelines for the management of high blood pressure in children and adolescents and the American Academy of Pediatrics Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents. Our aim is to summarize the main pathophysiological mechanisms through which IR causes HS and to highlight the specific principles of treatment of HS for children with DM.
More Related Videos
08:22Combined Intravital Microscopy and Contrast-enhanced Ultrasonography of the Mouse Hindlimb to Study Insulin-induced Vasodilation and Muscle Perfusion
Published on: March 20, 2017
08:13Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
Related Concept Videos
Hypertension II: Pathophysiology
Hypertension and Regulation of Blood Pressure
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Hypertension I: Introduction
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational